Macau, China vs New Zealand: Treatment success rate for patients treated for MDR-TB
Macau, China
100.0%
in 2022
New Zealand
100.0%
in 2022
Macau, China rank
1st
New Zealand rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Macau, China
- New Zealand
How they compare
Macau, China currently reports 100.0% against 100.0% in New Zealand, a difference of 0.0%.
The two have swapped places 5 times across 15 shared years of data; in 2007 it was Macau, China ahead.
Macau, China ranks 1st and New Zealand ranks 1st of 163 countries.
Across the 3 decades both report, Macau, China averaged higher in 2 and New Zealand in 1.
Head to head by decade
| Decade | Macau, China | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 77.5% | 46.5% | 31.0% | Macau, China |
| 2010s | 79.1% | 66.6% | 12.5% | Macau, China |
| 2020s | 58.3% | 100.0% | 41.7% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Macau, China or New Zealand?
- Macau, China, at 100.0% against 100.0% in New Zealand as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Macau, China and New Zealand?
- 0.0%, with Macau, China ahead.
- How many years of comparable data are there for Macau, China and New Zealand?
- 15 years are reported by both, from 2007 to 2022.
- How do Macau, China and New Zealand rank globally for treatment success rate for patients treated for mdr-tb?
- Macau, China ranks 1st and New Zealand ranks 1st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.